Expand ZTS Menu
ZTS MENU

ZTS Latest Press Releases

-- February 5, 2026 --

Zoetis Declares Second Quarter 2026 Dividend Business Wire 4:15 PM

-- December 30, 2025 --

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results Business Wire 8:30 AM

-- December 18, 2025 --

Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference Business Wire 8:30 AM

-- December 16, 2025 --

Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering Business Wire 1:15 AM

-- December 15, 2025 --

Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering Business Wire 7:09 AM

-- December 11, 2025 --

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase Business Wire 4:15 PM

-- December 5, 2025 --

Zoetis Receives Health Canada Approval for Portela (relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats Business Wire 8:30 AM

-- December 2, 2025 --

Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast Business Wire 7:30 AM

-- November 26, 2025 --

Zoetis Receives European Commission Marketing Authorization for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs Business Wire 4:15 PM

-- November 20, 2025 --

Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference Business Wire 8:30 AM

-- November 19, 2025 --

Zoetis to Host Innovation Webcast Business Wire 8:30 AM

-- November 4, 2025 --

Zoetis Announces Third Quarter 2025 Results Business Wire 7:00 AM

-- November 3, 2025 --

Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026 Business Wire 4:15 PM

-- October 29, 2025 --

Zoetis Receives European Commission Marketing Authorization for Portela (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats Business Wire 8:30 AM

-- October 28, 2025 --

Zoetis Appoints Stephanie Tilenius to its Board of Directors Business Wire 8:30 AM

-- October 15, 2025 --

Zoetis Announces Health Canada Approval of Lenivia (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs Business Wire 7:00 AM

-- October 10, 2025 --

Zoetis Receives Positive Opinion from CVMP for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs Business Wire 4:15 PM

-- October 9, 2025 --

Zoetis Declares Fourth Quarter 2025 Dividend Business Wire 4:15 PM

-- September 30, 2025 --

Zoetis Receives Conditional Approval for Dectomax-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle Business Wire 4:15 PM

-- September 23, 2025 --

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results Business Wire 8:30 AM

-- September 12, 2025 --

Zoetis Receives Positive Opinion from CVMP for Portela (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats Business Wire 12:11 PM
Market Data Delayed 15 Minutes